RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015
Jan 2011 - 124 pages - $1,740
Innovations in the Delivery of Cancer Therapies
Jan 2011 - 231 pages - $3,835
Lymphoma Therapy Area Pipeline Report
Nov 2010 - 233 pages - $1,495
Hodgkin Lymphoma Therapy Area Pipeline Report
Nov 2010 - 143 pages - $1,495
Non-Hodgkin Lymphoma Therapy Area Pipeline Report
Nov 2010 - 622 pages - $1,495
Cutaneous T-cell Lymphoma Therapy Area Pipeline Report
Nov 2010 - 101 pages - $1,495
Millenium: The Takeda Oncology Company – Product Pipeline Review – Q4 2010
Dec 2010 - 92 pages - $500
Cutaneous T-Cell Lymphoma - Pipeline Review, Q4 2010
Dec 2010 - 47 pages - $500
Nucleic Acid Drug Delivery Technologies: Players, products & prospects to 2018 (Volume III)
Jun 2009 - 110 pages - $1,040
Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)
May 2011 - 5 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Oral solid del
Cachet del
Therapeutic target
Oncology del
Lymphoma del
Development phase
Phase III/IV del

Browse By

Therapeutic target
Hodgkin's lymphoma
Lymphoma, AIDS-related
Neoplastic disease
Non-Hodgkins lymphoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us